HOME >> BIOLOGY >> NEWS
Optimizing protein's 'death domain' halts leukemia in laboratory study

BOSTON--A part of the system that causes cells to self-destruct when they are damaged or unneeded has been harnessed to kill leukemia cells in mice, say scientists at the Dana-Farber Cancer Institute. The discovery could aid in the discovery of new drugs for cancer and other diseases.

The researchers plucked a critical "death domain" from a key molecule in the self-destruction mechanism of a cell, stiffened its Slinky-like structure with chemical "staples," and used it as a highly specific weapon to destroy leukemia cells. The findings will be published in the Sept. 3 issue of the journal Science.

"We have demonstrated an approach for getting at potential new drugs by using natural sequences [of amino acids] that have known biological effects," says Stanley J. Korsmeyer, MD, of Dana-Farber, co-senior author of the paper. "In this case we took the critical killer domain out of a pro-death molecule and chemically reinforced it, so we were able to get it into cancer cells and kill them."

Loren D. Walensky, MD, PhD, of Dana-Farber and Children's Hospital Boston is the paper's first author and Gregory L. Verdine, PhD, of Harvard University, is co- senior author.

Korsmeyer and his colleagues have pioneered studies of apoptosis, or programmed cell death, that rids the body of damaged or unneeded cells. Apoptosis is directed by a complex collection of proteins in a yin-yang-like balance and is activated by a variety of external and internal signals. Some of the proteins set in motion a cell's death, while other "survival" proteins act to prevent programmed cell death.

One hallmark of cancer is that an excess of anti-death or survival proteins overwhelms the system when it is trying shut down the abnormal cell, causing the cell to reproduce, dangerously out of control, when it should be dying.

The pro-death part of the apoptosis toolbox includes a number of molecules known as BH3-only proteins. To ensure that cells destroy th
'"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
2-Sep-2004


Page: 1 2 3

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. A proteins role in progressive renal disease
3. Rb proteins role in retina development is key to understanding devastating eye cancer
4. Researchers view proteins structural changes in real time
5. Misfolding the key to proteins ability to kill brain cells
6. Researchers solve killer proteins crime
7. Biologists discover proteins impace on plant-water balance
8. Penn researchers proteins link to leukemia
9. Gene with key role in replicating pox viruses also halts inflammation
10. UT Southwestern research halts narcolepsy symptoms
11. Discovery may be first plant cell surface molecule that halts cell proliferation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/8/2019)... LA JOLLA, Calif. (PRWEB) , ... September 06, ... ... and the Board of Directors of Nanosens Innovations have each authorized the respective ... would become a subsidiary of Cardea, with the Nanosens brand representing a series ...
(Date:8/27/2019)... (PRWEB) , ... August 26, 2019 , ... Shoreline ... to the strain level, has hired Bill McKenzie as its CEO and Karen Woodward ... to help Shoreline Biome meet growing demand for its products and expand the company’s ...
(Date:8/25/2019)... ... 2019 , ... BioInformatics, part of Science and Medicine Group, ... helps connect companies with a network of thousands of life science and medical ... is moving faster than ever, and we have built a qualitative offering to ...
Breaking Biology News(10 mins):
(Date:8/6/2019)... ... August 06, 2019 , ... The National Science ... of a community project that will engage middle and early high school students ... “A Youth-Led Citizen Science Network for Community Environmental Assessment.” Collaborative partners presenting the ...
(Date:7/26/2019)... , ... July 25, 2019 , ... ... leaders through off-the-record collaboration and dialogue, today announces its Boston BD ... Hotel. As part of Biotech Week Boston , the event provides an ...
(Date:7/19/2019)... Calif. (PRWEB) , ... July 18, 2019 , ... ... also known as “Ravi Everest,” will be joining forces with California-based charity Coalition ... held from July 20-22nd. Coalition Duchenne raises awareness and funding for Duchenne muscular ...
(Date:7/17/2019)... , ... July 16, 2019 , ... ... to a recent report from Kalorama Information. Abbott, Roche and Siemens Healthineers and ... Kalorama Information’s latest report, Worldwide Market for Point-of-Care (POC) Diagnostics . , ...
Breaking Biology Technology:
Cached News: